October 2025 FDA Recall Aerotab Pain Reliever by Aero Healthcare
D-0155-2026 - Labeling

This Class II drug recall was voluntarily initiated by Aero Healthcare on October 17, 2025 for the product Aerotab Pain Reliever. The FDA reported the reason for recall as labeling. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0155-2026

Reason for Recall
Labeling: Label Mix-up. This issue affects the outer box labeling only. The box incorrectly states the ingredients Acetaminophen 500mg and Caffeine 65mg. The inner pouch correctly states the ingredients are Aspirin (NSAID)*500mg and Caffeine 32.5mg.
Initiated
10-17-2025
Reported
11-12-2025
Quantity
N/A

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Acetaminophen 500mg Caffeine 65mg caplets, packaged as 2 caplets per packet further packaged in a 50-count box, AERO TAB, Manufactured for AERO HEALTHCARE US, Valley-Cottage, NY, 10989, NDC 55305-135-01

Batch or Lot Expiration Information

Lot# 9282, Exp Date: 2026-09-01
Lot# 9310, Exp Date: 2026-11-01